Development of anti-LGI1 autoimmune encephalitis outcome rating score using the Rasch analysis
{{output}}
Background: Anti-LGI1 autoimmune encephalitis is an immunotherapy-responsive condition with growing interest in clinical trial development. However, the lack of reliable outcome measures is a major barrier. We aim to design a dis... ...
